TGTX vs. BYRN
TGTX (TG Therapeutics, Inc.) and BYRN (Byrna Technologies Inc.) are both stocks. TGTX operates in Biotechnology (Healthcare), while BYRN operates in Aerospace & Defense (Industrials). Over the past 10 years, TGTX returned 24.86%/yr vs 4.88%/yr for BYRN. At a 0.09 correlation, their price movements are largely independent.
Performance
TGTX vs. BYRN - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, TGTX achieves a 91.61% return, which is significantly higher than BYRN's -76.98% return. Over the past 10 years, TGTX has outperformed BYRN with an annualized return of 24.86%, while BYRN has yielded a comparatively lower 4.88% annualized return.
TGTX
- 1D
- -3.28%
- 1M
- 18.88%
- 6M
- 100.63%
- YTD
- 91.61%
- 1Y
- 54.02%
- 3Y*
- 31.01%
- 5Y*
- 7.20%
- 10Y*
- 24.86%
BYRN
- 1D
- -1.90%
- 1M
- -40.08%
- 6M
- -77.79%
- YTD
- -76.98%
- 1Y
- -83.17%
- 3Y*
- -1.63%
- 5Y*
- -28.95%
- 10Y*
- 4.88%
TGTX vs. BYRN - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
TGTX TG Therapeutics, Inc. | 91.61% | -0.96% | 76.23% | 44.38% | -37.74% | -63.48% | 368.65% | 170.73% | -50.00% | 76.34% |
BYRN Byrna Technologies Inc. | -76.98% | -41.72% | 350.86% | -18.49% | -41.27% | -7.93% | 663.16% | 26.67% | 7.14% | -30.00% |
Correlation
The correlation between TGTX and BYRN is 0.09, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.09 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.13 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.20 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.12 |
Correlation (All Time) Calculated using the full available price history since Feb 23, 2011 | 0.09 |
The correlation between TGTX and BYRN shifts across timeframes, from 0.09 (all time) to 0.20 (5 years), reflecting how their relationship changes across market environments.
Fundamentals
TGTX:
$8.74B
BYRN:
$87.68M
TGTX:
$2.88
BYRN:
-$0.16
TGTX:
13.06
BYRN:
0.84
TGTX:
15.68
BYRN:
1.54
TGTX:
$700.35M
BYRN:
$108.86M
TGTX:
$581.54M
BYRN:
$57.17M
TGTX:
$156.88M
BYRN:
-$3.55M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
TGTX vs. BYRN — Risk / Return Rank
TGTX
BYRN
TGTX vs. BYRN - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for TG Therapeutics, Inc. (TGTX) and Byrna Technologies Inc. (BYRN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| TGTX | BYRN | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +2.17 | ||
| Sortino ratioReturn per unit of downside risk | +4.10 | ||
| Omega ratioGain probability vs. loss probability | 1.23 | 0.69 | +0.54 |
| Calmar ratioReturn relative to maximum drawdown | 1.59 | -0.99 | +2.58 |
| Martin ratioReturn relative to average drawdown | 2.87 | -1.65 | +4.53 |
Loading charts...
Drawdowns
TGTX vs. BYRN - Drawdown Comparison
The maximum TGTX drawdown since its inception was -99.52%, which is greater than BYRN's maximum drawdown of -92.51%. Use the drawdown chart below to compare losses from any high point for TGTX and BYRN.
Loading charts...
Drawdown Indicators
| TGTX | BYRN | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.52% | -92.51% | -7.01% |
Max Drawdown (1Y)Largest decline over 1 year | -32.66% | -86.01% | +53.35% |
Max Drawdown (3Y)Largest decline over 3 years | -69.77% | -88.70% | +18.93% |
Max Drawdown (5Y)Largest decline over 5 years | -90.34% | -92.51% | +2.17% |
Max Drawdown (10Y)Largest decline over 10 years | -93.19% | -92.51% | -0.68% |
Current DrawdownCurrent decline from peak | -75.53% | -88.70% | +13.17% |
Average DrawdownAverage peak-to-trough decline | -91.36% | -52.50% | -38.86% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 18.01% | 51.63% | -33.62% |
Volatility
TGTX vs. BYRN - Volatility Comparison
The current volatility for TG Therapeutics, Inc. (TGTX) is 12.22%, while Byrna Technologies Inc. (BYRN) has a volatility of 46.46%. This indicates that TGTX experiences smaller price fluctuations and is considered to be less risky than BYRN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| TGTX | BYRN | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 12.22% | 46.46% | -34.24% |
Volatility (6M)Calculated over the trailing 6-month period | 34.37% | 74.13% | -39.76% |
Volatility (1Y)Calculated over the trailing 1-year period | 47.15% | 82.31% | -35.16% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 87.77% | 75.22% | +12.55% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 86.78% | 96.16% | -9.38% |
Dividends
TGTX vs. BYRN - Dividend Comparison
Neither TGTX nor BYRN has paid dividends to shareholders.
Financials
TGTX vs. BYRN - Financials Comparison
This section allows you to compare key financial metrics between TG Therapeutics, Inc. and Byrna Technologies Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
TGTX vs. BYRN - Profitability Comparison
TGTX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, TG Therapeutics, Inc. reported a gross profit of 171.41M and revenue of 204.92M. Therefore, the gross margin over that period was 83.7%.
BYRN - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Byrna Technologies Inc. reported a gross profit of 1.78M and revenue of 16.39M. Therefore, the gross margin over that period was 10.9%.
TGTX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, TG Therapeutics, Inc. reported an operating income of 34.80M and revenue of 204.92M, resulting in an operating margin of 17.0%.
BYRN - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Byrna Technologies Inc. reported an operating income of -12.85M and revenue of 16.39M, resulting in an operating margin of -78.4%.
TGTX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, TG Therapeutics, Inc. reported a net income of 19.78M and revenue of 204.92M, resulting in a net margin of 9.7%.
BYRN - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Byrna Technologies Inc. reported a net income of -10.09M and revenue of 16.39M, resulting in a net margin of -61.6%.
Frequently Asked Questions
TGTX and BYRN have a correlation of 0.09, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
BYRN has higher volatility (46.46%) compared to TGTX (12.22%). In terms of maximum drawdown, TGTX dropped -99.52% vs BYRN's -92.51%.
TGTX currently has the higher Sharpe Ratio (1.10 vs -1.07), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for TGTX and BYRN
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer